Neuronal Mimicry in Tumors: Lessons from Neuroscience to Tackle Cancer

Overview

Journal Cancer Metastasis Rev

Specialty Oncology

Date 2025 Feb 11

PMID 39934425

Authors

Hanan Bloomer

Haley B Dame

Savannah R Parker

Madeleine J Oudin

Affiliations

Soon will be listed here.

Abstract

Cellular plasticity and the ability to avoid terminal differentiation are hallmarks of cancer. Here, we review the evidence that tumor cells themselves can take on properties of neurons of the central nervous system, which can regulate tumor growth and metastasis. We discuss recent evidence that axon guidance molecules and regulators of electrical activity and synaptic transmission, such as ion channels and neurotransmitters, can drive the oncogenic and invasive properties of tumor cells from a range of cancers. We also review how FDA-approved treatments for neurological disorders are being tested in pre-clinical models and clinical trials for repurposing as anti-cancer agents, offering the potential for new therapies for cancer patients that can be accessed more quickly.

References

House C, Wang B, Ceniccola K, Williams R, Simaan M, Olender J . Voltage-gated Na+ Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling. Sci Rep. 2015; 5:11541. PMC: 4476109. DOI: 10.1038/srep11541. View

Gao Z, Han X, Zhu Y, Zhang H, Tian R, Wang Z . Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling. Cell Death Dis. 2021; 12(5):414. PMC: 8058342. DOI: 10.1038/s41419-021-03692-x. View

Yang M, James A, Suman R, Kasprowicz R, Nelson M, OToole P . Voltage-dependent activation of Rac1 by Na 1.5 channels promotes cell migration. J Cell Physiol. 2019; 235(4):3950-3972. PMC: 6973152. DOI: 10.1002/jcp.29290. View

Hammadi M, Chopin V, Matifat F, Dhennin-Duthille I, Chasseraud M, Sevestre H . Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. J Cell Physiol. 2012; 227(12):3837-46. DOI: 10.1002/jcp.24095. View

Brackenbury W, Chioni A, Diss J, Djamgoz M . The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat. 2006; 101(2):149-60. PMC: 4122814. DOI: 10.1007/s10549-006-9281-1. View

Takasugi M, Okada R, Takahashi A, Chen D, Watanabe S, Hara E . Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2. Nat Commun. 2017; 8:15729. PMC: 5467215. DOI: 10.1038/ncomms15728. View

Chamaraux-Tran T, Mathelin C, Aprahamian M, Joshi G, Tomasetto C, Diemunsch P . Antitumor Effects of Lidocaine on Human Breast Cancer Cells: An and Experimental Trial. Anticancer Res. 2017; 38(1):95-105. DOI: 10.21873/anticanres.12196. View

Xia S, He C, Zhu Y, Wang S, Li H, Zhang Z . GABAR-Induced EGFR Transactivation Promotes Migration of Human Prostate Cancer Cells. Mol Pharmacol. 2017; 92(3):265-277. DOI: 10.1124/mol.116.107854. View

Lengrand J, Pastushenko I, Vanuytven S, Song Y, Venet D, Sarate R . Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature. 2023; 620(7973):402-408. PMC: 7615210. DOI: 10.1038/s41586-023-06372-2. View

10.

Lu G, Du R, Dong J, Sun Y, Zhou F, Feng F . Cancer associated fibroblast derived SLIT2 drives gastric cancer cell metastasis by activating NEK9. Cell Death Dis. 2023; 14(7):421. PMC: 10344862. DOI: 10.1038/s41419-023-05965-z. View

11.

Tavora B, Mederer T, Wessel K, Ruffing S, Sadjadi M, Missmahl M . Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis. Nature. 2020; 586(7828):299-304. PMC: 8088828. DOI: 10.1038/s41586-020-2774-y. View

12.

Wechman S, Emdad L, Sarkar D, Das S, Fisher P . Vascular mimicry: Triggers, molecular interactions and in vivo models. Adv Cancer Res. 2020; 148:27-67. PMC: 7594199. DOI: 10.1016/bs.acr.2020.06.001. View

13.

Nelson M, Yang M, Millican-Slater R, Brackenbury W . Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo. Oncotarget. 2015; 6(32):32914-29. PMC: 4741739. DOI: 10.18632/oncotarget.5441. View

14.

Oudin M, Jonas O, Kosciuk T, Broye L, Guido B, Wyckoff J . Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression. Cancer Discov. 2016; 6(5):516-31. PMC: 4854754. DOI: 10.1158/2159-8290.CD-15-1183. View

15.

Karagiannis G, Pastoriza J, Wang Y, Harney A, Entenberg D, Pignatelli J . Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Sci Transl Med. 2017; 9(397). PMC: 5592784. DOI: 10.1126/scitranslmed.aan0026. View

16.

Worzfeld T, Offermanns S . Semaphorins and plexins as therapeutic targets. Nat Rev Drug Discov. 2014; 13(8):603-21. DOI: 10.1038/nrd4337. View

17.

Chakraborty G, Kumar S, Mishra R, Patil T, Kundu G . Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLoS One. 2012; 7(3):e33633. PMC: 3308985. DOI: 10.1371/journal.pone.0033633. View

18.

Sung P, Rama N, Imbach J, Fiore S, Ducarouge B, Neves D . Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity. Cancer Res. 2019; 79(14):3651-3661. DOI: 10.1158/0008-5472.CAN-18-2952. View

19.

Sun H, Luo L, Lal B, Ma X, Chen L, Hann C . A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis. Nat Commun. 2016; 7:10339. PMC: 4742836. DOI: 10.1038/ncomms10339. View

20.

Patocka J, Wu Q, Nepovimova E, Kuca K . Phenytoin - An anti-seizure drug: Overview of its chemistry, pharmacology and toxicology. Food Chem Toxicol. 2020; 142:111393. DOI: 10.1016/j.fct.2020.111393. View